Sumitomo Mitsui Trust Holdings Inc. Cuts Stock Holdings in Humana Inc. (NYSE:HUM)

Sumitomo Mitsui Trust Holdings Inc. trimmed its position in shares of Humana Inc. (NYSE:HUMFree Report) by 7.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 337,682 shares of the insurance provider’s stock after selling 27,433 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc. owned approximately 0.28% of Humana worth $117,081,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in HUM. Rakuten Securities Inc. purchased a new position in shares of Humana during the 4th quarter valued at approximately $25,000. Gradient Investments LLC lifted its holdings in Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 40 shares in the last quarter. Cetera Trust Company N.A purchased a new position in Humana during the fourth quarter valued at $28,000. Private Wealth Management Group LLC acquired a new stake in shares of Humana in the fourth quarter valued at about $32,000. Finally, Carolinas Wealth Consulting LLC increased its stake in shares of Humana by 274.1% during the fourth quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock worth $46,000 after purchasing an additional 74 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have commented on HUM shares. Argus lowered Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, March 13th. Oppenheimer dropped their price target on Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a research report on Thursday, April 25th. Royal Bank of Canada decreased their price objective on Humana from $415.00 to $353.00 and set an “outperform” rating on the stock in a report on Thursday, April 25th. Wells Fargo & Company reduced their target price on shares of Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Finally, Barclays lowered their price target on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 2nd. Fourteen investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and an average target price of $409.55.

Read Our Latest Stock Report on Humana

Humana Stock Down 3.2 %

Humana stock opened at $362.85 on Thursday. The company has a market capitalization of $43.72 billion, a PE ratio of 22.59, a price-to-earnings-growth ratio of 2.17 and a beta of 0.51. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. Humana Inc. has a fifty-two week low of $298.61 and a fifty-two week high of $530.54. The firm has a 50 day moving average price of $345.69 and a 200 day moving average price of $350.79.

Humana (NYSE:HUMGet Free Report) last posted its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.12 by $1.11. Humana had a return on equity of 17.76% and a net margin of 1.82%. The firm had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. During the same quarter in the previous year, the business earned $9.38 EPS. The company’s quarterly revenue was up 10.7% compared to the same quarter last year. Research analysts expect that Humana Inc. will post 16.27 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio (DPR) is currently 22.04%.

Humana Company Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.